(Q37986605)

English

Diagnostic performance of Gallium-68 somatostatin receptor PET and PET/CT in patients with thoracic and gastroenteropancreatic neuroendocrine tumours: a meta-analysis

scientific article published on 20 February 2012

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 August 2017

0 references

Diagnostic performance of Gallium-68 somatostatin receptor PET and PET/CT in patients with thoracic and gastroenteropancreatic neuroendocrine tumours: a meta-analysis (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 August 2017

0 references

0 references

0 references

1 reference

based on heuristic

inferred from title

Giorgio Treglia

1

1 reference

Europe PubMed Central

PubMed publication ID

26 August 2017

object named as

Guido Rindi

3

0 references

author name string

Paola Castaldi

2

1 reference

Europe PubMed Central

PubMed publication ID

26 August 2017

Alessandro Giordano

4

1 reference

Europe PubMed Central

PubMed publication ID

26 August 2017

Vittoria Rufini

5

1 reference

Europe PubMed Central

PubMed publication ID

26 August 2017

publication date

20 February 2012

1 reference

Europe PubMed Central

PubMed publication ID

26 August 2017

1 reference

Europe PubMed Central

PubMed publication ID

26 August 2017

42

1 reference

Europe PubMed Central

PubMed publication ID

26 August 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

26 August 2017

80-87

1 reference

Europe PubMed Central

PubMed publication ID

26 August 2017

Neuroendocrine neoplasms of the gut and pancreas: new insights

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9631-1

21 January 2018

Radiopeptide imaging and therapy in Europe

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9631-1

21 January 2018

Radiopeptide imaging and therapy in the United States

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9631-1

21 January 2018

Imaging of neuroendocrine tumors

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9631-1

21 January 2018

ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: somatostatin receptor imaging with (111)In-pentetreotide

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9631-1

21 January 2018

NANETS consensus guidelines for the diagnosis of neuroendocrine tumor

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9631-1

21 January 2018

Cost comparison of 111In-DTPA-octreotide scintigraphy and 68Ga-DOTATOC PET/CT for staging enteropancreatic neuroendocrine tumours.

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9631-1

21 January 2018

Meta-DiSc: a software for meta-analysis of test accuracy data.

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9631-1

21 January 2018

Biokinetics and imaging with the somatostatin receptor PET radioligand (68)Ga-DOTATOC: preliminary data

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9631-1

21 January 2018

Evaluation of the pharmacokinetics of 68Ga-DOTATOC in patients with metastatic neuroendocrine tumours scheduled for 90Y-DOTATOC therapy

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9631-1

21 January 2018

Comparison of 68Ga-DOTATOC PET and 111In-DTPAOC (Octreoscan) SPECT in patients with neuroendocrine tumours

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9631-1

21 January 2018

Functional imaging of neuroendocrine tumors with combined PET/CT using 68Ga-DOTATATE (DOTA-DPhe1,Tyr3-octreotate) and 18F-FDG.

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9631-1

21 January 2018

Comparison between 68Ga-DOTA-NOC and 18F-DOPA PET for the detection of gastro-entero-pancreatic and lung neuro-endocrine tumours

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9631-1

21 January 2018

68Ga-DOTA-NOC: a new PET tracer for evaluating patients with bronchial carcinoid

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9631-1

21 January 2018

A comparison of 68Ga-DOTATATE and 18F-FDG PET/CT in pulmonary neuroendocrine tumors

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9631-1

21 January 2018

Intraindividual comparison of 68Ga-DOTA-TATE and 18F-DOPA PET in patients with well-differentiated metastatic neuroendocrine tumours

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9631-1

21 January 2018

The impact of 68Ga-DOTATOC positron emission tomography/computed tomography on the multimodal management of patients with neuroendocrine tumors

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9631-1

21 January 2018

Role of (68)Ga-DOTATOC PET/CT in the evaluation of primary pulmonary carcinoids

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9631-1

21 January 2018

68Ga-DOTA-NOC PET/CT imaging of neuroendocrine tumors: comparison with ¹¹¹In-DTPA-octreotide (OctreoScan®).

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9631-1

21 January 2018

The role of 68Ga-DOTATATE PET in patients with neuroendocrine tumors and negative or equivocal findings on 111In-DTPA-octreotide scintigraphy

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9631-1

21 January 2018

Ga-68 DOTATOC PET, endoscopic ultrasonography, and multidetector CT in the diagnosis of duodenopancreatic neuroendocrine tumors: a single-centre retrospective study.

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9631-1

21 January 2018

68Ga-DOTATOC PET/CT of neuroendocrine tumors: spotlight on the CT phases of a triple-phase protocol.

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9631-1

21 January 2018

Gastroenteropancreatic neuroendocrine tumors: new insights in the diagnosis and therapy.

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9631-1

21 January 2018

Role of biological targeted therapies in gastroenteropancreatic neuroendocrine tumours

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9631-1

21 January 2018

The role of integrated (18)F-FDG PET/CT in identification of ectopic ACTH secretion tumors

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9631-1

21 January 2018

68Ga-DOTATOC versus 68Ga-DOTATATE PET/CT in functional imaging of neuroendocrine tumors.

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9631-1

21 January 2018

68Ga-DOTA-Tyr3-Octreotide PET in Neuroendocrine Tumors: Comparison with Somatostatin Receptor Scintigraphy and CT

1 reference

https://api.crossref.org/works/10.1007%2FS12020-012-9631-1

21 January 2018

Gallium-68-DOTA-NOC PET/CT of patients with gastroenteropancreatic neuroendocrine tumors: a prospective single-center study

1 reference

https://pubmed.ncbi.nlm.nih.gov/22350660

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Natural history of gastro-entero-pancreatic and thoracic neuroendocrine tumors. Data from a large prospective and retrospective Italian epidemiological study: the NET management study.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22350660

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S12020-012-9631-1

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37986605&oldid=2201140346"